References and Recommended Reading
Fisher B, Costantino JP, Wickerham DL, et al.: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998, 90:1371–1388.
Vogel VG, Costantino JP, Wickerham DL, et al.: Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006, 295:2727–2741.
Vogel VG, Costantino JP, Wickerham DL, et al.: Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 trial: preventing breast cancer. Cancer Prev Res 2010, 3(6):696–706.
Fisher B, Costantino J, Wickerham DL, et al.: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005, 97:1652–1662.
Powles TJ, Ashley S, Tidy A, et al.: Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. J Natl Cancer Inst 2007, 99:283–290.
Cuzick J, Forbes JF, Sestak I, et al.: Long-term results of tamoxifen prophylaxis for breast cancer—96 month follow-up of the randomized IBIS-1 trial. J Natl Cancer Inst 2007, 99:272–282.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bevers, T.B. Breast Cancer Prevention: An Update of the STAR Trial. Curr. Treat. Options in Oncol. 11, 66–69 (2010). https://doi.org/10.1007/s11864-010-0124-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11864-010-0124-2